Question 1

What is Transgene?

Accepted Answer

Transgene is a Company.

Question 2

How often does Transgene appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was Transgene first tracked by Ergen?

Accepted Answer

First tracked on Apr 13, 2026.

Question 4

When was Transgene last mentioned in news?

Accepted Answer

Last active on May 28, 2026.

Question 5

What is Transgene's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Transgene in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Transgene?

Accepted Answer

Transgene Completes TG4050 Phase 2 Randomization (Apr 13, 2026, 6 articles).

Question 8

How did the "Transgene Completes TG4050 Phase 2 Randomization" event impact Transgene?

Accepted Answer

Transgene announced the completion of patient randomization in the Phase 2 part of its Phase 1/2 clinical trial for TG4050, a significant milestone for the company's individualized neoantigen therapeutic vaccine platform.

Question 9

How did the "Transgene's TG-MVA Mpox Vaccine Data" event impact Transgene?

Accepted Answer

Transgene announced positive preclinical data for its Task Group MVACEF vaccine candidates against mpox, which could lead to further development and potential partnerships, enhancing its market position and value.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.